Skip to content

ICU Medical CH-70Recalls & reported problems

Icu Medical, Inc. · ChemoClave® Universal Vented Vial Spike · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
4
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00840619025854), received between Aug 1, 2019 and Oct 18, 2024 — classified as 4 malfunctions.

The most frequently reported specific device problem is “Fluid/Blood Leak” (4 reports).

9 other recalls cover devices cleared under the same FDA submission (K173477); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fluid/Blood Leak4

Patient problems

  • No Consequences Or Impact To Patient3
  • Chemical Exposure1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 18, 2024Fluid/Blood Leak; Fluid/Blood Leak

    THE CUSTOMER PROVIDED ADDITIONAL INFORMATION AS FOLLOWS: WHILE MAKING UP IMMUNOTHERAPY AND DRAWING UP THE TREATMENT IN A CLOSED SYSTEM VIA A SYRINGE, THE CHEMO CLAVE UNIVERSAL VENTED SPIKE SHOT THE IMMUNOTHERAPY OUT OF A CRACK IN THE SIDE OF THE EQUIPMENT THAT WAS DISCOVERED TO BE DEFECTIVE. THIS WENT ON THE PREPARER'S GLOVES AND A PUDDLE OF IMMUNOTHERAPY WAS PRESENT IN THE BLUE CLINICAL TRAY. THE PRODUCT WAS STORED IN ROOM TEMPERATURE IN THE STOREROOM INSIDE OF A CUPBOARD.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20478440 ↗
  • MalfunctionAug 12, 2020Fluid/Blood Leak; Fluid/Blood Leak

    THE EVENT INVOLVED A CHEMOCLAVE¿ UNIVERSAL VENTED VIAL SPIKE WHERE A SPILL OF CHEMOTHERAPY DRUG WAS NOTED FROM HOLE OF THE FILTER DURING THE ASPIRATION PHASE. THERE WAS NO ADVERSE EVENT REPORTED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10396166 ↗
  • MalfunctionFeb 5, 2020Fluid/Blood Leak; Fluid/Blood Leak

    THE EVENT INVOLVED A CHEMOCLAVE® UNIVERSAL VENTED VIAL SPIKE THAT DURING ASPIRATION, USING A SYRINGE OF OXALIPLATIN, A LEAK WAS NOTED FROM THE SPIKE CONTAMINATING THE WORK AREA HOOD AND THE OPERATOR¿S FOREARM¿. THERE IS PATIENT INVOLVEMENT, AND NO HARM WAS REPORTED.

    Patient problems: Chemical Exposure; No Consequences Or Impact To Patient

    MAUDE report 9670691 ↗
  • MalfunctionAug 1, 2019Fluid/Blood Leak; Fluid/Blood Leak

    THE DATE OF THE EVENT IS UNKNOWN. THE PRODUCT INVOLVED IS AN ICU MEDICAL CHEMOCLAVE UNIVERSAL VENTED VIAL SPIKE. IT WAS REPORTED THAT AT THE TIME OF THE INSERTION OF THE SPIKE, DROPS FROM A LEAKAGE ARE FOUND INSIDE THE VIAL CONTAINING AN ANTICANCER DRUG.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8851762 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K173477. One submission often covers many models, so check the product and lot details in each record.

  • Z-3159-2026 · May 12, 2026 · Open, Classified
    Oncology sets with drip chambers
  • Z-3161-2026 · May 12, 2026 · Open, Classified
    IV Sets with drip chambers
  • Z-1580-2021 · Mar 16, 2021 · Open, Classified
    REF CH3625 5" (13 cm) Appx 0.50 ml, Smallbore Trifuse Ext Set w/3 ChemoClave (Purple, Green Rings), Spiros w/Red Cap, 3 Clamps - Product Usage: provides access for the administrat
  • Z-1578-2021 · Mar 16, 2021 · Open, Classified
    REF CH3011 30" (76 cm) Appx 3.3 mL, 20 Drop Admin Set w/Integrated ChemoClave Drip Chamber, Spiros w/Red Cap, Bag Hanger - Product Usage: provides access for the administration o
  • Z-1576-2021 · Mar 16, 2021 · Open, Classified
    REF CH2020 20mL Syringe w/Spinning Spiros, Red Cap - Product Usage: provides access for the administration of fluids from a container to a patient s vascular system through the adm
  • Z-1577-2021 · Mar 16, 2021 · Open, Classified
    REF CH2060 60mL Syringe w/Spinning Spiros, Red Cap - Product Usage: provides access for the administration of fluids from a container to a patient s vascular system through the adm
  • Z-1579-2021 · Mar 16, 2021 · Open, Classified
    REF CH3020 40" (102 cm) Appx. 4.8 ml, 20 Drop Admin Set w/In-Line Chamber, 2 Spiros", Hanger - Product Usage: provides access for the administration of fluids from a container to a
  • Z-0704-2021 · Aug 31, 2020 · Open, Classified
    3mL Syringe w/Spinning Spiros, Red Cap, REF: CH2003; 5mL Syringe w/Spinning Spiros, Red Cap, REF: CH2005; 10mL Syringe w/Spinning Spiros, Red Cap, REF: CH2010; 20mL Syringe w/Spinn
  • Z-0248-2021 · Jul 6, 2020 · Terminated
    6.5 IN (17 cm) APPX 0.78 ml, Ext Set w/Clave Clear, Clave 4-Way Stopcock, Spiros Red Cap;1 unit per pouch, 50 pouches per case. UDI:(01)10887709098878(17)241201(30)50(10)4493149.

Other Closed antineoplastic and hazardous drug reconstitution and transfer system devices

All Closed antineoplastic and hazardous drug reconstitution and transfer system devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page